Progress in Adenoviral Capsid-Display Vaccines

Abstract excerpt

Adenoviral vectored vaccines against infectious diseases are currently in clinical trials due to their capacity to induce potent antigen-specific B- and T-cell immune responses. Heterologous prime-boost vaccination with adenoviral vector and, for example, adjuvanted protein-based vaccines can further enhance antigen-specific immune responses. Although leading to potent immune responses, these heterologous...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Virus-based gene therapy research
• Share to RNA Interference and Gene Delivery
• Share to CAR-T cell therapy research